Technology Listings

Novel Inhibitors of NOX2/ROS


Novel therapeutics for treatment of various inflammatory airway conditions including chronic obstructive pulmonary disease (COPD).

Key Benefits
  • NOX2/ROS inhibitors have potential for use in a wide variety of clinical indications.
  • Current treatments are weakly effective or provide only symptomatic relief for inflammatory airway diseases.
Technical Summary

NADPH-oxidase 2 (NOX2) and reactive oxygen species (ROS) is currently an unestablished drug target. There are few NOX inhibitors in clincial trials. Emory scientists have developed three chemical series of novel NOX2/ROS inhibitors, with different NOX2/ROS isoform selectivities and therefore different uses for clinical indications. The inhibitors can be used for the treatment of inflammatory airway diseases such as COPD, acute respiratory distress syndrome, acute lung inflammation as well as hypertension, ischemia/reperfusion injury (including stroke, myocardial infarction, transplanted organs), diabetes, atherosclerosis, Alzheimer's disease, various cancers, Parkinson's disease, pulmonary fibrosis, liver fibrosis, cardiac hypertrophy, diabetic nephropathy, diabetic neuropathy, scar formation, skin aging and damage, psoriasis, and as an agent for preservation of organs during transplantation.

Developmental Stage

Lead identified and in vivo studies have been performed in mouse models of the flu and liver fibrosis.

Patent Information
App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Divisional EP 15153831.1 2886120 10/25/2011 6/19/2019 10/25/2031 Issued
Nationalized PCT - United States United States 13/876,869 9,868,728 3/29/2013 1/16/2018 10/25/2031 Issued
Nationalized PCT - Foreign Canada 2,816,022   4/25/2013     Pending
Divisional United States 15/147,531 5/5/2016     Issued
Tech ID: NCS.10
Published: 2/10/2015
Drug Discovery

Hyeon (Sean) Kim
Licensing Associate
Emory University

Thota Ganesh
David Lambeth
Susan Smith
Aiming Sun

Metabolic Diseases
Small Molecule